1.
Najar W, Barette L, Penther D, Maarek O, Stamatoullas A, Penichoux J, Veresezan E-L, Daliphard S, Buchonnet G, Bobee V, Jardin F, de Botton S, Fenaux P, Camus V. Myelodysplastic syndrome with cryptic 5q deletions in young male patients showing sustained response to lenalidomide. haematol [Internet]. 2020Sep.10 [cited 2026Feb.6];. Available from: https://haematologica.org/article/view/13124